RYAPOSE

Details for Australian Trade Mark No. 1096703 (hide)

Owner Eli Lilly and Company a Indiana corporation

Convention US 4 August 2005 78/685823

Service Spruson & Ferguson

Various Convention priority claimed: 4 August 2005, United States of America, No. 78/685823 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF BLOOD DISORDERS, CANCER/ONCOLOGY, CARDIOVASCULAR DISEASES

Filing Date 31 January 2006

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases and disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Event Publications

23 February 2006 Application filed

2 March 2006 Application Accepted

29 June 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1096704-LIQUIDITY HUNTER

1096702